147 related articles for article (PubMed ID: 2259889)
1. Dysfunction of HLA-B27.
Ivanyi P
Scand J Rheumatol Suppl; 1990; 87():51-69; discussion 69. PubMed ID: 2259889
[TBL] [Abstract][Full Text] [Related]
2. The pathogenetic role of HLA-B27 in chronic arthritis.
López de Castro JA
Curr Opin Immunol; 1998 Feb; 10(1):59-66. PubMed ID: 9523113
[TBL] [Abstract][Full Text] [Related]
3. Bacteria-specific cytotoxic CD8+ T cells: a missing link in the pathogenesis of the HLA-B27-associated spondylarthropathies.
Hermann E; Fleischer B; Meyer zum Büschenfelde KH
Ann Med; 1994 Oct; 26(5):365-9. PubMed ID: 7530015
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity among evolutionarily distant major histocompatibility complex class I molecules (HLA-B27 and H-2Kk) revealed by xenoreactive T lymphocytes.
Frangoulis B; Reboul M; Rocca A; Pla M
Eur J Immunol; 1993 Feb; 23(2):338-42. PubMed ID: 8436169
[TBL] [Abstract][Full Text] [Related]
5. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice.
Khare SD; Lee S; Bull MJ; Hanson J; Luthra HS; Hammerling GJ; David CS
Hum Immunol; 1999 Feb; 60(2):116-26. PubMed ID: 10027779
[TBL] [Abstract][Full Text] [Related]
6. The role of HLA-B27 in spondyloarthritis.
Allen RL; Bowness P; McMichael A
Immunogenetics; 1999 Nov; 50(3-4):220-7. PubMed ID: 10602882
[TBL] [Abstract][Full Text] [Related]
7. Structural polymorphism and function of HLA-B27.
López de Castro JA
Curr Opin Rheumatol; 1995 Jul; 7(4):270-8. PubMed ID: 7547103
[TBL] [Abstract][Full Text] [Related]
8. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice.
Nickerson CL; Luthra HS; David CS
Ann Rheum Dis; 1990 Jun; 49 Suppl 1():426-33. PubMed ID: 2115764
[TBL] [Abstract][Full Text] [Related]
9. Guilt by association: HLA-B27 and ankylosing spondylitis.
Benjamin R; Parham P
Immunol Today; 1990 Apr; 11(4):137-42. PubMed ID: 2187471
[TBL] [Abstract][Full Text] [Related]
10. Fully functional HLA B27-restricted CD4+ as well as CD8+ T cell responses in TCR transgenic mice.
Roddis M; Carter RW; Sun MY; Weissensteiner T; McMichael AJ; Bowness P; Bodmer HC
J Immunol; 2004 Jan; 172(1):155-61. PubMed ID: 14688321
[TBL] [Abstract][Full Text] [Related]
11. HLA class-I-transgenic mice as model system to study MHC-restricted antigen recognition in man.
Weiss EH; Schliesser G; Botteron C; McMichael A; Riethmüller G; Kievits F; Ivanyi P; Brem G
Scand J Rheumatol Suppl; 1990; 87():91-6. PubMed ID: 2259893
[TBL] [Abstract][Full Text] [Related]
12. HLA-B27 and disease: a consequence of inadvertent antigen presentation?
Benjamin R; Parham P
Rheum Dis Clin North Am; 1992 Feb; 18(1):11-21. PubMed ID: 1561398
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides.
Khare SD; Bull MJ; Hanson J; Luthra HS; David CS
J Immunol; 1998 Jan; 160(1):101-6. PubMed ID: 9551961
[TBL] [Abstract][Full Text] [Related]
14. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice.
Khare SD; Luthra HS; David CS
Semin Immunol; 1998 Feb; 10(1):15-23. PubMed ID: 9529652
[TBL] [Abstract][Full Text] [Related]
15. A high incidence of Shigella-induced arthritis in a primate species: major histocompatibility complex class I molecules associated with resistance and susceptibility, and their relationship to HLA-B27.
Urvater JA; McAdam SN; Loehrke JH; Allen TM; Moran JL; Rowell TJ; Rojo S; López de Castro JA; Taurog JD; Watkins DI
Immunogenetics; 2000 Apr; 51(4-5):314-25. PubMed ID: 10803844
[TBL] [Abstract][Full Text] [Related]
16. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
Qian BF; Tonkonogy SL; Balfour Sartor R
Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
[TBL] [Abstract][Full Text] [Related]
17. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
Sorrentino R; Böckmann RA; Fiorillo MT
Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069
[TBL] [Abstract][Full Text] [Related]
18. The solvent-inaccessible Cys67 residue of HLA-B27 contributes to T cell recognition of HLA-B27/peptide complexes.
Appel H; Kuon W; Kuhne M; Hülsmeyer M; Kollnberger S; Kuhlmann S; Weiss E; Zeitz M; Wucherpfennig K; Bowness P; Sieper J
J Immunol; 2004 Dec; 173(11):6564-73. PubMed ID: 15557146
[TBL] [Abstract][Full Text] [Related]
19. Structure, function, and disease association of HLA-B27.
López de Castro JA
Curr Opin Rheumatol; 1994 Jul; 6(4):371-7. PubMed ID: 8068508
[TBL] [Abstract][Full Text] [Related]
20. Immunization of HLA-B27 transgenic and non transgenic mice with Salmonella typhimurium results predominantly in the generation of proliferative T cell responses.
Ringrose JH; Yard BA; Verjans GM; Boog CJ
Clin Rheumatol; 1996 Jan; 15 Suppl 1():79-85. PubMed ID: 8835510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
